Post-approval studies (Phase 4)Study completedNCT04588480
What this trial is testing
Study to Evaluate the Safety, Tolerability, and Immunogenicity of an RNA Vaccine Candidate Against COVID-19 in Healthy Japanese Adults
Who this might be right for
SARS-CoV-2 InfectionCOVID-19
BioNTech SE 160